Saturday, July 11, 2026

Drug profile · INN

sulphur hexafluoride

sulphur hexafluoride (SONOVUE) is a diagnostic agent.

EMA: approved Various (V08) V08DA05
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — sulphur hexafluoride
Class
Various (V08)
Route
Patents
0
Programs
2
Data quality
0.83

Quick answer

sulphur hexafluoride (SONOVUE) is a diagnostic agent.

Key facts

INN sulphur hexafluoride
Brand SONOVUE
Mechanism Diagnostic agent
Therapeutic class Various (V08)
ATC code V08DA05

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
EMA approved

Pipeline programs

  1. D20181321 Phase 2 · PARItec · recurrent primary supratentorial malignant brain tumors in c
  2. Eliquis film-coated tablets for Left ventricular thrombosis., A… Approved · George Institute for · Left ventricular thrombosis., Acute mycocardial infarction (

Related & competitor drugs

  1. besilesomab Various (V09)
  2. deferasirox Various (V03)
  3. ferric citrate coordination complex Various (V03)
  4. folic acid Various (V04)
  5. sevelamer carbonate Various (V03)
  6. sugammadex sodium Various (V03)

Frequently asked questions

What is sulphur hexafluoride?

sulphur hexafluoride (SONOVUE) is a diagnostic agent.

What is the brand name for sulphur hexafluoride?

SONOVUE is a marketed brand name for sulphur hexafluoride. Check FDA Drugs@FDA for the current US label holder and prescribing information.